Peyronie’s disease creates fibrous plaques that bend the penis and impair sexual function. Focused shockwave therapy concentrates acoustic energy at the plaque site, creating targeted micro-trauma that triggers tissue remodelling and softens hardened calcification and scar tissue. Unlike invasive surgery, this non-surgical approach preserves anatomy, requires no anaesthesia, and delivers progressive results over weeks. This guide explains how the treatment works, what outcomes to expect, and how to access it in the UK.
Unlike oral medications, which often yield inconsistent results, focused shockwave therapy provides a localised, physical intervention to remodel the underlying fibrosis. The mechanism operates through three biological stages: acoustic wave penetration, cellular stimulation, and tissue regeneration.
The treatment targets the exact location of plaque formation within the tunica albuginea (the fibrous sheath surrounding erectile tissue). Energy concentration at this focal point initiates a cascade of healing responses that restore penile elasticity and straightness.
Consult a qualified doctor to determine if your condition is suitable for this therapy.
Focused shockwave therapy differs fundamentally from radial shockwave devices. Focused systems concentrate energy at a single point (the plaque), while radial systems disperse energy across a wider area. This precision matters: focused delivery maximises therapeutic effect on the target tissue while minimising surrounding damage.
The biological cascade begins immediately. Mechanical stimulation activates fibroblasts—cells responsible for collagen production—triggering a controlled inflammatory response. This inflammation is therapeutic: it signals the body to break down old, dysfunctional tissue and rebuild healthy structures. These are the same growth factor and tissue repair pathways that make PRP therapy so effective for pain management, underscoring the shared biology across regenerative medicine modalities.
Peyronie’s disease creates a vicious cycle: penile trauma triggers abnormal healing, forming fibrous plaques that restrict flexibility and worsen curvature. Shockwave therapy permanently breaks down the fibrous plaques which cause the penis to bend.
The fragmentation process is gradual but cumulative. Each treatment session adds mechanical stress to calcified deposits, weakening their structure. Simultaneously, the inflammatory response recruits healing cells that reabsorb broken-down plaque material and replace it with healthy, elastic tissue.
| Tissue Response | Timeline | Clinical Outcome |
| Microtrauma induction | Immediate (0-48 hours) | Growth factor release begins |
| Inflammatory phase | Days 1-7 | Fibroblast activation, plaque softening |
| Neovascularization | Weeks 2-6 | Blood flow restoration, tissue oxygenation |
| Collagen remodelling | Weeks 4-12 | Curvature reduction, elasticity improvement |
| Tissue maturation | Months 3-6 | Maximum functional benefit achieved |
Growth factors—particularly VEGF (vascular endothelial growth factor) and HGF (hepatocyte growth factor)—orchestrate this repair. These signalling molecules recruit stem cells and endothelial cells to rebuild damaged blood vessels, restoring oxygen delivery to erectile tissue.
Peyronie’s disease progresses through two distinct phases, and treatment timing is critical. The acute phase (0-12 months) involves active inflammation, progressive curvature, and penile pain. The stable phase (12+ months) shows plateau curvature, resolved pain, and calcified plaque.
The American Urological Association identifies extracorporeal shockwave therapy as an effective, non-invasive intervention for managing penile pain in the active phase, citing Grade B clinical evidence. However, for curvature correction, stable phase treatment yields superior outcomes because inflammation has subsided and plaque has hardened—making it more responsive to mechanical fragmentation.
Treating during acute phase risks exacerbating inflammation and worsening curvature. A qualified doctor must assess disease phase through clinical history and imaging before proceeding. Ultrasound visualises plaque location, size, and calcification degree—essential data for treatment planning.
Clinical evidence demonstrates measurable improvements in both penile curvature and erectile function. Each session typically lasts 20 to 30 minutes with no anaesthetic required, and many men begin noticing improvements in curvature or function over several weeks as tissue remodelling takes effect. Results are progressive: early sessions initiate healing; later sessions consolidate gains.
The primary outcome metric is restoration of sexual function—the ability to achieve satisfactory intercourse. Curvature reduction is the objective measurement, with typical improvements ranging 20-30 degrees over a complete treatment course. Erectile function recovery occurs concurrently as vascular repair restores blood flow to penile tissue.
Low-intensity shockwave protocols (0.09 mJ/mm²) are preferred over high-intensity approaches because they deliver therapeutic benefit with minimal adverse effects. Multiple clinical trials support efficacy: the ONDELA trial (completed 2024) demonstrated safety and efficacy; ongoing Mayo Clinic research examines combined therapy approaches.
Patient satisfaction rates exceed 70% in published cohorts, with quality-of-life improvements extending beyond sexual function to psychological confidence and relationship satisfaction. The non-invasive nature means patients maintain normal daily activities throughout treatment—no downtime, no activity restrictions. For female partners who may be experiencing their own intimacy concerns alongside their partner’s recovery, non-surgical sexual rejuvenation treatments for women offer comparable evidence-based, non-invasive approaches to restored function and confidence.
| Outcome Metric | Baseline | Post-Treatment (6 months) | Improvement Rate |
| Penile curvature (degrees) | 45-60° | 15-30° | 20-30° reduction |
| Erectile function (IIEF score) | 12-18 | 22-28 | +10-15 points |
| Intercourse satisfaction | Poor/Fair | Good/Excellent | 70%+ improvement |
| Penile pain (VAS scale) | 6-8/10 | 0-2/10 | 75%+ pain reduction |
| Patient satisfaction | — | — | 72% very satisfied |
Results vary by individual; consult a qualified doctor for realistic expectations based on your specific condition.
The standard treatment protocol spans 6-12 weeks with 12 sessions delivered 1-2 times weekly. This spacing allows tissue healing between sessions while maintaining therapeutic momentum. Sessions are brief—20-30 minutes—and performed in-clinic with no preparation required.
The in-clinic experience is straightforward. You’ll be positioned comfortably, the treatment area will be cleaned, and the shockwave handpiece will be applied directly to the plaque site. Sensation varies: some patients report mild pressure; others feel minimal discomfort. No anaesthesia is needed.
Post-treatment recovery is immediate. You can resume normal activities the same day—work, exercise, sexual activity. Mild bruising may appear but resolves within days. Progressive improvements emerge over weeks as tissue remodelling accumulates. Supporting your body’s repair capacity with a structured nutrition plan—ensuring adequate protein, vitamin C, zinc, and anti-inflammatory foods—can meaningfully support the neovascularization and collagen remodelling processes triggered by each shockwave session.
Surgery remains an option for severe cases unresponsive to non-surgical treatment, but it carries significant risks. Surgery is usually only recommended in severe cases for patients who fail to respond to non-surgical treatments and have curvature for longer than 12 months, with risks including impotence post-surgery, nerve injury, loss of sensitivity, decreased blood flow and infection risk.
Shockwave therapy avoids these complications entirely. It addresses the root cause—plaque and fibrosis—rather than masking symptoms. Oral medications (like pentoxifylline or colchicine) manage symptoms but don’t remodel tissue. Penile traction therapy requires 6-9 months of daily use; shockwave delivers results in 12 weeks.
| Treatment Type | Invasiveness | Recovery Time | Efficacy for Curvature | Typical Cost Range |
| Focused shockwave | Non-invasive | None (same-day) | 20-30° reduction | £3,000-£5,000 |
| Surgical plication | Surgical incision | 3-6 weeks | 30-40° reduction | £8,000-£15,000 |
| Penile traction | Non-invasive | N/A (ongoing) | 10-15° reduction | £500-£2,000 |
| Oral medications | Non-invasive | N/A | Symptom relief only | £100-£300 |
Non-surgical options preserve natural penile anatomy and function. Shockwave therapy stands apart because it regenerates tissue rather than simply stretching or chemically treating it.
Accessing shockwave therapy begins with a confidential consultation where a qualified doctor assesses your suitability. This evaluation determines disease phase, plaque characteristics, and realistic outcomes specific to your condition. The process is straightforward and judgment-free.
Leading UK clinics offer flexible appointment options—evening and weekend slots—to accommodate busy schedules. Initial phone consultations are confidential and allow you to discuss symptoms, ask questions, and understand the treatment pathway before committing to in-clinic assessment.
The pre-treatment evaluation is comprehensive but efficient. Your doctor will review medical history, symptom onset, curvature severity, and erectile function status. This conversation establishes baseline measurements against which post-treatment improvements are tracked.
Imaging is essential. Ultrasound visualises plaque location, size, and degree of calcification—data that guides treatment planning and predicts response likelihood. Doppler ultrasound also assesses penile blood flow, identifying vascular dysfunction that may coexist with curvature. For men who want a thorough independent health review before beginning a treatment course, a Private GP in London on Harley Street can provide comprehensive cardiovascular, vascular, and metabolic screening that informs the specialist’s treatment planning.
Certain conditions exclude patients from shockwave therapy: active infection, anticoagulant use (blood thinners), bleeding disorders, or pregnancy-related conditions. Your doctor will clarify these during assessment. Disease-focused evaluation determines whether curvature stems primarily from plaque (responsive to shockwave) or fibrosis alone (may require alternative approaches).
Your suitability depends on individual factors; a consultation is essential to confirm eligibility.
The initial phone consultation is confidential and judgment-free. You’ll discuss your symptoms, goals, and concerns with a trained consultant who explains the non-surgical procedure, realistic outcomes, and next steps. This conversation answers your questions before you commit to in-clinic assessment.
Prepare to discuss: when symptoms began, curvature direction and severity, current erectile function, any prior treatments attempted, and relevant medical history (medications, bleeding disorders, infections). This information helps the consultant assess preliminary suitability and explain whether shockwave therapy is appropriate for your situation.
The consultant will outline the treatment protocol (12 sessions over 6-12 weeks), typical outcomes (20-30° curvature reduction, erectile function improvement), and what to expect during and after treatment. They’ll also discuss cost, payment options, and aftercare support available at the clinic.
Book your confidential phone consultation to discuss your treatment options and receive a personalised plan.
Does shockwave therapy actually work for Peyronie’s disease? Yes; clinical trials demonstrate 20-30° curvature reduction and erectile function improvement in 70%+ of patients, with results progressive over 6-12 weeks.
Can I access shockwave therapy for Peyronie’s on the NHS? NHS availability is limited; most patients access treatment privately through specialist clinics offering focused shockwave devices.
What are the side effects or downsides of focused shockwave therapy? Side effects are minimal: mild bruising, temporary discomfort, or rare penile swelling; serious complications are exceptionally rare with low-intensity protocols.
How many shockwave therapy sessions do I need for Peyronie’s disease? Standard protocol is 12 sessions delivered 1-2 times weekly over 6-12 weeks; some patients benefit from 2-4 booster sessions 6-12 months later.
Is shockwave therapy suitable if I’m in the acute phase of Peyronie’s disease? Shockwave can manage acute-phase pain but is most effective for curvature correction in stable phase (12+ months); consult a doctor to determine your phase.
How does low intensity shockwave therapy differ from other acoustic wave treatments? Low-intensity protocols (0.09 mJ/mm²) deliver therapeutic benefit with minimal adverse effects; high-intensity approaches carry greater risk of tissue damage.
Dr SW Clinics
We offer 0% finance on all our treatments, please call the clinic to find out more +44 (0)20 3006 8459